A Safety and Efficacy Study of BOTOX in Korean Adults With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 29 May 2016
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors Allergan
- 07 Apr 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 13 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
- 13 Jan 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.